Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Mucinoses Stories

2012-04-10 06:28:21

A Free, Informational Webinar Hosted by the Scleroderma Research Foundation on April 25, 2012 SAN FRANCISCO, April 10, 2012 /PRNewswire-USNewswire/ -- The Scleroderma Research Foundation (SRF) is presenting the next webinar in their series for people living with scleroderma and others directly or indirectly affected by the disease. The free webinar will educate viewers to better understand the disease, what is being done to find a cure and what new treatments are on the horizon....

2012-04-04 10:26:26

"Walk for Cure" Empowers Autoimmune Disease Community DANVERS, Mass., April 4, 2012 /PRNewswire-USNewswire/ -- The "Walk for Cure" Video Awareness campaign launches today to support the Scleroderma Foundation and its signature fundraising and awareness event, "Stepping Out to Cure Scleroderma." This multichannel media campaign hopes to spread more awareness about scleroderma, a rare autoimmune disease. WALKFORCURE.ORG is a video sharing website featuring a wall of scleroderma...

2012-03-20 09:30:29

Patient biopsies reveal potential new target for therapy A genetic pathway previously known for its role in embryonic development and cancer has been identified as a target for systemic sclerosis, or scleroderma, therapy. The finding, discovered by a cross-disciplinary team led by John Varga, MD, John and Nancy Hughes Distinguished Professor of Rheumatology at Northwestern University Feinberg School of Medicine, was recently published in the journal Arthritis & Rheumatism. "We...

2012-02-29 08:03:00

Funds Three Key Scleroderma Research Projects DANVERS, Mass., Feb. 29, 2012 /PRNewswire-USNewswire/ -- The U.S. Department of Defense announced that it will fund three important scleroderma research projects as part of its Fiscal Year 2011 Peer Reviewed Medical Research Program. The following investigators have been awarded grant funding: Sandeep Agarwal, M.D., Ph.D., assistant professor of medicine, Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston. Robert...

2012-02-03 14:00:00

National Congressional Call-in Day Wednesday, Feb. 8 DANVERS, Mass., Feb. 3, 2012 /PRNewswire-USNewswire/ -- The Scleroderma Foundation unveiled a unique awareness campaign today with the help of OrgSpring, an online technology firm that helps nonprofit organizations build and maintain relationships with supporters. Through the campaign, people living with scleroderma, their family members, friends and others are urged to change their Facebook Profile Timeline cover images in...

2012-02-01 12:00:00

Eight Researchers Receive Grant Funding DANVERS, Mass., Feb. 1, 2012 /PRNewswire-USNewswire/ -- The Scleroderma Foundation's commitment to fund research remains strong despite the continued difficult economic climate. At a time when many organizations and government agencies are cutting back on vital research funding, the Board of Directors unanimously voted to increase the Foundation's research funding from the budgeted $1 million to $1.2 million for 2012. The Foundation...

2011-10-10 06:51:00

EASTBOURNE, England, October 10, 2011 /PRNewswire/ -- Daval International today announced positive results from its Double-Blind Placebo-Controlled Phase II Clinical Study evaluating the safety and tolerability of AIMSPRO given as a monotherapy to patients with Late Stage Established Diffuse Cutaneous Systemic Sclerosis (diffuse scleroderma). The study evaluated the effects of 4.5mg/ml doses of AIMSPRO, administered subcutaneously, twice weekly for 26 weeks compared with...

2011-08-19 12:00:00

Dinesh Khanna, M.D., M.Sc., Honored at Annual Banquet in San Francisco DANVERS, Mass., Aug. 19, 2011 /PRNewswire-USNewswire/ -- The Scleroderma Foundation named Dinesh Khanna, M.D., M.Sc., its 2011 Doctor of the Year during this year's National Patient Education Conference held last month in San Francisco. The award recognizes a skilled physician or researcher for his or her involvement within the Foundation, and for helping provide guidance and support to the organization's patient...

2011-08-12 12:30:00

LAKE STEVENS, Wash., Aug. 12, 2011 /PRNewswire-USNewswire/ -- Ryan Roy, of Bellingham, Wash., only has been doing triathlons for two years. In 2010, he completed three races at sprint and Olympic distances. For 2011, in addition to competing in sprint and Olympic triathlons, and his first half marathon in Seattle, Ryan will race Sunday in his first Ironman competition while battling for a cause that means a lot to him and his family. On Sunday, Aug. 14, Ryan will battle the Ironman 70.3...

2011-07-12 22:19:22

Systemic scleroderma has slowed Tracy Zinn but it has not stopped her from working. Thanks in part to determination and an accommodating employer, Zinn is now in her 13th year as an account executive for a firm that produces educational software. But, many with the incapacitating disease are not as fortunate. In the United States, the work disability rate for people with systemic scleroderma, also known as systemic sclerosis, is two to three times that of people with some other rheumatic...